The emerging therapy of the medication represents a exciting advance in the management of type 2 diabetes. Distinct from existing medications, tirzepatide targets dual pathways – GLP-1 and GIP – leading to improved https://tirzepatidepeptide066751.wssblogs.com/41903514/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment